Sing Investments & Finance Limited (SGX:S35)

Augmedix Revenue

Sing Investments & Finance had revenue of 38.13M SGD in the half year ending December 31, 2024, with 8.73% growth. This brings the company's revenue in the last twelve months to 79.09M, up 16.16% year-over-year. In the year 2024, Sing Investments & Finance had annual revenue of 71.82M with 5.22% growth.

• Revenue (ttm): 79.09M
• Revenue Growth: +16.16%
• P/S Ratio: 3.98
• Revenue / Employee: 485.23K
• Employees: 163
• Market Cap: 314.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	71.82M	3.56M	5.22%
Dec 31, 2023	68.26M	-3.61M	-5.02%
Dec 31, 2022	71.87M	8.66M	13.70%
Dec 31, 2021	63.21M	16.34M	34.86%
Dec 31, 2020	46.87M	-1.63M	-3.36%